Browsing Royal Victoria Eye and Ear Hospital by Subjects
Now showing items 1-1 of 1
The case for intraocular delivery of PPAR agonists in the treatment of diabetic retinopathy.Systemic therapeutics targeting the peroxisome proliferator-activated receptors have been found to be beneficial in the treatment of diabetic retinopathy. In this paper, we provide a rationale for the use of these therapeutics as intraocular agents. In addition, we introduce the peroxisome proliferator-activated receptors and describe their functions in response to the drugs.